$ANIP
ANI PHARMACEUTICALS INC
Runway:cash-flow +
NasdaqMarket cap: —CIK 0001023024
Upcoming catalysts
0 surfacedNo catalysts surfaced for ANIP yet.
Drug pipeline
carboprost tromethamine
baclofen
memantine and donepezil hydrochlorides
colestipol hydrochloride
nitazoxanide
fesoterodine fumarate
iluvien
chronic non-infectious uveitis affecting the posterior segment of the eye
Recent catalysts
FDA approvalMar 14, 2025· 500d ago
$ANIPANI PHARMACEUTICALS INC
iluvien · chronic non-infectious uveitis affecting the posterior segment of the eye
“the U.S. Food and Drug Administration has approved an expanded label for ILUVIEN ® (fluocinolone acetonide intravitreal implant) that includes an indication for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye”
Mar 14, 2025
500d ago
FDA approvalFeb 3, 2025· 539d ago· success
$ANIPANI PHARMACEUTICALS INC
nitazoxanide
“openFDA ORIG (UNKNOWN) approval of NITAZOXANIDE — application ANDA214844”
Feb 3, 2025
539d ago
FDA approvalJan 25, 2024· 914d ago· success
$ANIPANI PHARMACEUTICALS INC
carboprost tromethamine
“openFDA ORIG (UNKNOWN) approval of CARBOPROST TROMETHAMINE — application ANDA215901”
Jan 25, 2024
914d ago
FDA approvalDec 15, 2023· 955d ago· success
$ANIPANI PHARMACEUTICALS INC
memantine and donepezil hydrochlorides
“openFDA ORIG (UNKNOWN) approval of MEMANTINE AND DONEPEZIL HYDROCHLORIDES — application ANDA208237”
Dec 15, 2023
955d ago
FDA approvalJun 8, 2023· 1145d ago· success
$ANIPANI PHARMACEUTICALS INC
baclofen
“openFDA ORIG (UNKNOWN) approval of BACLOFEN — application ANDA217252”
Jun 8, 2023
1145d ago
FDA approvalMar 10, 2023· 1235d ago· success
$ANIPANI PHARMACEUTICALS INC
colestipol hydrochloride
“openFDA ORIG (UNKNOWN) approval of COLESTIPOL HYDROCHLORIDE — application ANDA216517”
Mar 10, 2023
1235d ago
FDA approvalJan 4, 2023· 1300d ago· success
$ANIPANI PHARMACEUTICALS INC
fesoterodine fumarate
“openFDA ORIG (UNKNOWN) approval of FESOTERODINE FUMARATE — application ANDA204504”
Jan 4, 2023
1300d ago